Companies House 12000732 2025-05-31 2025-05-31 2024-06-01 false iso4217:GBP xbrli:pure 12000732 2023-06-01 2024-05-31 12000732 2025-05-31 12000732 2024-06-01 2025-05-31 12000732 2024-05-31 12000732 curr:PoundSterling 2024-06-01 2025-05-31 12000732 uk-bus:CompanyLimitedByGuarantee 2024-06-01 2025-05-31 12000732 uk-bus:FRS102 2024-06-01 2025-05-31 12000732 uk-bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 12000732 uk-bus:FullAccounts 2024-06-01 2025-05-31 12000732 uk-bus:RegisteredOffice 2024-06-01 2025-05-31 12000732 uk-bus:Director1 2024-06-01 2025-05-31 12000732 uk-bus:Director2 2024-06-01 2025-05-31 12000732 uk-bus:Director3 2024-06-01 2025-05-31 12000732 uk-bus:Director4 2024-06-01 2025-05-31 12000732 uk-bus:Director5 2024-06-01 2025-05-31 12000732 uk-bus:Director6 2024-06-01 2025-05-31 12000732 uk-bus:Director7 2024-06-01 2025-05-31 12000732 uk-bus:Director8 2024-06-01 2025-05-31 12000732 uk-bus:Director9 2024-06-01 2025-05-31 12000732 uk-bus:Director10 2024-06-01 2025-05-31 12000732 uk-bus:Director11 2024-06-01 2025-05-31 12000732 uk-bus:Director12 2024-06-01 2025-05-31 12000732 uk-bus:Director13 2024-06-01 2025-05-31 12000732 uk-bus:Director14 2024-06-01 2025-05-31 12000732 uk-bus:Director15 2024-06-01 2025-05-31 12000732 uk-bus:Director16 2024-06-01 2025-05-31 12000732 uk-bus:Director17 2024-06-01 2025-05-31 12000732 uk-bus:Director18 2024-06-01 2025-05-31 12000732 uk-bus:Director19 2024-06-01 2025-05-31 12000732 uk-bus:Director20 2024-06-01 2025-05-31 12000732 uk-bus:Director21 2024-06-01 2025-05-31 12000732 uk-bus:CompanySecretary1 2024-06-01 2025-05-31 12000732 core:AfterOneYear 2025-05-31 12000732 core:AfterOneYear 2024-05-31 12000732 core:WithinOneYear 2025-05-31 12000732 core:WithinOneYear 2024-05-31 12000732 core:WithinOneYear 2024-06-01 2025-05-31 12000732 core:AfterOneYear 2025-05-31 12000732 core:AfterOneYear 2024-05-31 12000732 core:AfterOneYear 2024-06-01 2025-05-31 12000732 core:ShareCapital 2025-05-31 12000732 core:ShareCapital 2024-05-31 12000732 core:SharePremium 2025-05-31 12000732 core:SharePremium 2024-05-31 12000732 core:OtherReservesSubtotal 2025-05-31 12000732 core:OtherReservesSubtotal 2024-05-31 12000732 core:RevaluationReserve 2025-05-31 12000732 core:RevaluationReserve 2024-05-31 12000732 core:RetainedEarningsAccumulatedLosses 2025-05-31 12000732 core:RetainedEarningsAccumulatedLosses 2024-05-31 12000732 1 2024-06-01 2025-05-31 12000732 2 2024-06-01 2025-05-31 12000732 3 2024-06-01 2025-05-31 12000732 core:LandBuildings 2024-06-01 2025-05-31 12000732 core:LandBuildings 2025-05-31 12000732 core:LandBuildings 2023-06-01 2024-05-31 12000732 core:LandBuildings 2024-05-31 12000732 core:PlantMachinery 2024-06-01 2025-05-31 12000732 core:PlantMachinery 2025-05-31 12000732 core:PlantMachinery 2023-06-01 2024-05-31 12000732 core:PlantMachinery 2024-05-31 12000732 core:FurnitureFittingsToolsEquipment 2024-06-01 2025-05-31 12000732 core:FurnitureFittingsToolsEquipment 2025-05-31 12000732 core:FurnitureFittingsToolsEquipment 2023-06-01 2024-05-31 12000732 core:FurnitureFittingsToolsEquipment 2024-05-31 12000732 core:OfficeEquipment 2024-06-01 2025-05-31 12000732 core:OfficeEquipment 2025-05-31 12000732 core:OfficeEquipment 2023-06-01 2024-05-31 12000732 core:OfficeEquipment 2024-05-31 12000732 core:Vehicles 2024-06-01 2025-05-31 12000732 core:Vehicles 2025-05-31 12000732 core:Vehicles 2023-06-01 2024-05-31 12000732 core:Vehicles 2024-05-31 12000732 core:NetGoodwill 2024-06-01 2025-05-31 12000732 core:NetGoodwill 2025-05-31 12000732 core:NetGoodwill 2023-06-01 2024-05-31 12000732 core:NetGoodwill 2024-05-31 12000732 core:IntangibleAssetsOtherThanGoodwill 2024-06-01 2025-05-31 12000732 core:IntangibleAssetsOtherThanGoodwill 2025-05-31 12000732 core:IntangibleAssetsOtherThanGoodwill 2023-06-01 2024-05-31 12000732 core:IntangibleAssetsOtherThanGoodwill 2024-05-31

# MEDCAN CLINICIANS SOCIETY CIC

## Company limited by guarantee

## Company Registration Number:
12000732 (England and Wales)

## Unaudited statutory accounts for the year ended 31 May 2025

## Period of accounts

## Start date: 1 June 2024

## End date: 31 May 2025

# MEDCAN CLINICIANS SOCIETY CIC

## Contents of the Financial Statements

for the Period Ended 31 May 2025

Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# MEDCAN CLINICIANS SOCIETY CIC

## Profit And Loss Account

for the Period Ended 31 May 2025

| 2025 | 2024
--- | --- | ---
| £ | £
Turnover: | 67,522 | 90,692
Cost of sales: | ( 2,365 ) | ( 12,644 )
Gross profit(or loss): | 65,157 | 78,048
Administrative expenses: | ( 60,244 ) | ( 74,417 )
Operating profit(or loss): | 4,913 | 3,631
Profit(or loss) before tax: | 4,913 | 3,631
Tax: | ( 933 ) | ( 239 )
Profit(or loss) for the financial year: | 3,980 | 3,392

# MEDCAN CLINICIANS SOCIETY CIC

## Balance sheet

As at 31 May 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Current assets
Debtors: | 3 | 1,044 | 4,816
Cash at bank and in hand: |  | 22,882 | 22,449
Total current assets: |  | 23,926 | 27,265
Creditors: amounts falling due within one year: | 4 | ( 6,694 ) | ( 9,687 )
Net current assets (liabilities): |  | 17,232 | 17,578
Total assets less current liabilities: |  | 17,232 | 17,578
Creditors: amounts falling due after more than one year: | 5 |  | ( 4,286 )
Accruals and deferred income: |  |  | ( 40 )
Total net assets (liabilities): |  | 17,232 | 13,252
Members' funds
Profit and loss account: |  | 17,232 | 13,252
Total members' funds: |  | 17,232 | 13,252

The notes form part of these financial statements

# MEDCAN CLINICIANS SOCIETY CIC

## Balance sheet statements

For the year ending 31 May 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 16 February 2026
and signed on behalf of the board by:

Name: Michael Barnes
Status: Director

The notes form part of these financial statements

# MEDCAN CLINICIANS SOCIETY CIC

## Notes to the Financial Statements

for the Period Ended 31 May 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# MEDCAN CLINICIANS SOCIETY CIC

## Notes to the Financial Statements

for the Period Ended 31 May 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 0 | 0

# MEDCAN CLINICIANS SOCIETY CIC

## Notes to the Financial Statements

for the Period Ended 31 May 2025

## 3. Debtors

| 2025 | 2024
--- | --- | ---
| £ | £
Trade debtors | 1,044 | 4,816
Total | 1,044 | 4,816

# MEDCAN CLINICIANS SOCIETY CIC

## Notes to the Financial Statements

for the Period Ended 31 May 2025

## 4. Creditors: amounts falling due within one year note

| 2025 | 2024
--- | --- | ---
| £ | £
Bank loans and overdrafts | 6,694 | 9,687
Total | 6,694 | 9,687

# MEDCAN CLINICIANS SOCIETY CIC

## Notes to the Financial Statements

for the Period Ended 31 May 2025

## 5. Creditors: amounts falling due after more than one year note

|  | 2024
--- | --- | ---
|  | £
Other creditors |  | 4,286
Total |  | 4,286

# COMMUNITY INTEREST ANNUAL REPORT

### MEDCAN CLINICIANS SOCIETY CIC

### Company Number: 12000732 (England and Wales)

### Year Ending: 31 May 2025

Company activities and impact

The Society is an independent clinician-led organisation which now has over 500 members. Our main purpose is to provide practical knowledge, guidance and support to clinicians in the medical cannabis sector. This year our membership has grown significantly and we have produced a series of new guidance booklets to support our members. We continue to provide monthly training and this year have taught about 200 new clinicians both in this country and abroad – in Romania, Greece and Malaysia. We now have international ambassadors in 16 countries. We have initiated a google.io group which enables members to ask anonymous clinical questions quickly and efficiently and receive replies for experienced clinicians world-wide.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

Kate Frost has received remuneration for consulting, which can be found under Staff Costs: Consulting on the profit and loss account.

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
16 February 2026

And signed on behalf of the board by:
Name: Michael Barnes
Status: Director